The GIBH CAS-CUHK Joint Research Laboratory on Stem Cell and Regenerative Medicine (the GIBH-CUHK Joint Lab), established by the joint efforts of the Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (GIBH, CAS) and the School of Biomedical Sciences, Chinese University of Hong Kong (CUHK), was officially inaugurated at CUHK in August 2012.

The Guangdong-Hong Kong Joint Laboratory for Stem Cell and Regenerative Medicine (the Guangdong-Hong Kong Joint Lab) is established based on the GIBH-CUHK Joint Lab and the Guangdong Provincial Key Laboratory for Stem Cell and Regenerative Medicine and was officially approved for construction by the Guangdong Department of Science and Technology in 2024.

The GIBH-CUHK and Guangdong-Hong Kong Joint Labs aim to harness the strengths of both institutions in their respective fields to achieve significant research breakthroughs in the field of stem cell and regenerative medicine in order to contribute to the advancement of biomedical sciences and healthcare.

The establishment of the two Joint Labs represents a significant and continuously deepening collaboration between GIBH and CUHK, serving as the vital international frontier base for both CUHK and GIBH, contributing to the strategic development of the Guangdong-Hong Kong-Macao Greater Bay Area and the national ‘Belt and Road’ initiative. The collaboration further strengthens scientific and technological cooperation between Guangdong and Hong Kong and presents new opportunities for the advancement of stem cell and regenerative medicine research in China.

The Joint Labs have high-level academic teams with reasonable knowledge structure, high education level, wide professional coverage, and strong technical force. A dedicated team of scientists is set up on each side and led by a Co-Director and a Deputy Director.

Prof. Pan Guangjin from GIBH is the Co- Director of the Joint Labs, and is also the project leader of the national key research and development program, the Chief Scientist of the 973 Program, an awardee in the CAS Hundred Talents Program (Outstanding), an outstanding talent of Guangdong Province's Special Support Plan. Prof. Chen Jiekai is the deputy Director from GIBH side, and is also the Winners of National Distinguished Youth Foundation. The GIBH team consists of 20 Principle Investigators and 30 Associate Investigators, mainly from the Guangdong Provincial Key Laboratory for Stem Cell and Regenerative Medicine.

Prof Chan Wai-Yee, is the Co-Director of the Joint Labs from Hong Kong side, who is currently the Pro-Vice-Chancellor and Vice-President (Strategic Developments) of the CUHK, and concurrently serves as the Director of the Institute for Tissue Engineering and Regenerative Medicine in CUHK and the Director of CUHK-BGI (Beijing Genome Institute) Innovation Institute of Trans-Omics. The Deputy Director from CUHK side is Prof. Feng Bo. The HKU team mainly comes from the School of Biomedical Sciences, CUHK. Other HKU team faculty members include Prof Chan Man Lok Andrew, Prof. Zhao Hui, Prof. Jiang Xiaohua, Prof Hui Xiaoyan Hannah, Prof Fok Kin Lam Ellis, Prof Gu Shen Linda, Prof. Cheung Hoi Hung Albert and Prof. Wang Wuming. Prof Chan Man Lok Andrew is the Director of the School of Biomedical Sciences, CUHK.

Several joint research teams composed of both GIBH and CUHK researchers have been working together efficiently, and have achieved great progress.